

FOLLOWUS
a.Laboratory of Novel Optoelectronic Technology for Ophthalmic Devices (NOTOD), School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China
b.National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
c.Department of vitreous and retinal center, Affiliated Eye Hospital of WenZhou Medical University, Hangzhou 310020, China
d.Department of Ophthalmology the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
yongliu@wmu.edu.cn (Y.L.)
changchun@wmu.edu.cn (C.C.Y.)
Received:13 October 2025,
Revised:2025-12-08,
Accepted:16 January 2026,
Online First:03 March 2026,
Published:05 April 2026
Scan QR Code
Duan, N.; Luo, X. R.; Zhou, Y. D.; Chai, J. Y.; Wang, J. Z.; Gao, J.; Ye, H. F.; Shan, S. Y.; Liu, Y.; Yu, C. C. Facile synthesis of an injectable redox/pH dual stimuli-responsive hydrogel system for drug release. Chinese J. Polym. Sci. https://doi.org/10.1007/s10118-026-3558-0
Ning Duan, Xin-Ran Luo, Yan-Di Zhou, et al. Facile Synthesis of An Injectable Redox/pH Dual Stimuli-responsive Hydrogel System for Drug Release[J/OL]. Chinese Journal of Polymer Science, 2026, 441-12.
Duan, N.; Luo, X. R.; Zhou, Y. D.; Chai, J. Y.; Wang, J. Z.; Gao, J.; Ye, H. F.; Shan, S. Y.; Liu, Y.; Yu, C. C. Facile synthesis of an injectable redox/pH dual stimuli-responsive hydrogel system for drug release. Chinese J. Polym. Sci. https://doi.org/10.1007/s10118-026-3558-0 DOI:
Ning Duan, Xin-Ran Luo, Yan-Di Zhou, et al. Facile Synthesis of An Injectable Redox/pH Dual Stimuli-responsive Hydrogel System for Drug Release[J/OL]. Chinese Journal of Polymer Science, 2026, 441-12. DOI: 10.1007/s10118-026-3558-0.
Multiresponsive hydrogels
capable of responding to more than one external stimulus
have demonstrated great utility in biomedical applications. This study presents a facile method for preparing an injectable
dual redox/pH-responsive hydrogel system based on poly(3
4-ethylenedioxythiophene):poly(4-styrenesulfonate) (PEDOT:PSS) for the controlled delivery of pharmacologically active bevacizumab (BEV). The hydrogel system was fabricated
via
a one-step physical crosslinking process by mixing PEDOT:PSS with BEV
leveraging electrostatic interactions
hydrogen bonding
and ionic crosslinking. The resulting PEDOT@BEV system exhibited a homogeneously porous structure
robust mechanical stability
and good biocompatibility. Under acidic (pH=5) or alkaline (pH=10) conditions
especially when coupled with elevated reactive oxygen species (ROS) levels
the as-prepared PEDOT@BEV achieved rapid BEV release. This may be attributed to PEDOT oxidation and charge repulsion. In contrast
BEV release remained stable under physiological conditions (pH=7.4
0 mmol/L H
2
O
2
).
In vitro
results supported that the resulting PEDOT@BEV demonstrated potent anti-angiogenic efficacy
significantly inhibiting cellular migration and tube formation of human retinal vascular endothelial cells (HRVECs). The vascular endothelial growth factor expression was further reduced. In a mouse model of corneal neovascularization
the PEDOT@BEV system enabled the continuous controlled release of BEV for over 14 days. It exhibited superior anti-angiogenic efficacy compared to free BEV treatment
more effectively reducing neovascularization and corneal inflammation. The designed platform in this work demonstrated versatility by successfully incorporating other therapeutic antibodies (
e.g.
rituximab
trastuzumab)
highlighting its potential for ta
ilored drug delivery in oncology and neovascular diseases. The outcome of this study offers a promising strategy for spatiotemporally controlled drug release in response to specific microenvironmental cues.
Cao, H.; Duan, L. X.; Zhang, Y.; Cao, J.; Zhang, K. Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity. Signal Transduct. Target. Ther. 2021 , 6 , 426..
Li, J.; Mooney, D. J. Designing hydrogels for controlled drug delivery. Nat. Rev. Mater. 2016 , 1 , 1..
Li, Z. Y.; Zhou, Y. Z.; Li, T. Y.; Zhang, J. J.; Tian, H. Stimuli-responsive hydrogels: fabrication and biomedical applications. View 2022 , 3 , 20200112..
Neumann, M.; di Marco, G.; Iudin, D.; Viola, M.; van Nostrum, C. F.; van Ravensteijn, B. G. P.; Vermonden, T. Stimuli-responsive hydrogels: the dynamic smart biomaterials of tomorrow. Macromolecules 2023 , 56 , 8377..
Wang, Y. Q.; Dou, X. Y.; Wang, H. F.; Wang, X.; Wu, D. C. Dendrimer-based hydrogels with controlled drug delivery property for tissue adhesion. Chinese J. Polym. Sci. 2021 , 39 , 1421−1430..
Yu, Y. B.; Cheng, Y.; Tong, J. Y.; Zhang, L.; Wei, Y.; Tian, M. Recent advances in thermo-sensitive hydrogels for drug delivery. J. Mater. Chem. 2021 , 9 , 2979..
Andrade, F.; Roca-Mele ndres, M. M.; Durán-Lara, E. F.; Rafael, D.; Schwartz, S. Jr. Stimuli-responsive hydrogels for cancer treatment: the role of pH, light, ionic strength and magnetic field. Cancers 2021 , 13 , 1164..
Monteiro, P. F.; Travanut, A.; Conte, C.; Alexander, C. Reduction-responsive polymers for drug delivery in cancer therapy—Is there anything new to discover. Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2021 , 13 , e1678..
Yang, Z. Y.; Yin, J.; Xin, L.; Li, Y. F.; Huang, Y. J.; Yuan, R.; Zhou, Y. Research advancement of DNA-based intelligent hydrogels: manufacture, characteristics, application of disease diagnosis and treatment. Chin. Chem. Lett. 2024 , 35 , 109558..
Zhang, J.; Lin, Y. D.; Lin, Z.; Wei, Q.; Qian, J. Q.; Ruan, R. J.; Jiang, X. C.; Hou, L. X.; Song, J. B.; Ding, J. X.; Yang, H. H. Stimuli-responsive nanoparticles for controlled drug delivery in synergistic cancer immunotherapy. Adv. Sci. 2022 , 9 , 2103444..
Ovais, M.; Mukherjee, S.; Pramanik, A.; Das, D.; Mukherjee, A.; Raza, A.; Chen C. Y. Designing stimuli-responsive upconversion nanoparticles that exploit the tumor microenvironment. Adv. Mater. 2020 , 32 , 2000055..
Pan, Y. J.; Chen, Y. Y.; Wang, D. R.; Wei, C.; Guo, J.; Lu, D. R.; Chu, C. C.; Wang, C. C. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release. Biomaterials 2012 , 33 , 6570..
Wang, Z.; Shi, J. J.; Gu, M. Y.; Zhang, X. J.; Sheng, R. L. A versatile strategy to construct surface functionalized pH/redox dual stimuli-responsive nanogels for targeted drug delivery. J. Appl. Polym. Sci. 2024 , 141 , e54908..
John, J. V.; Uthaman, S.; Augustine, R.; Chen, H.; Park, I. K.; Kim, I. pH/redox dual stimuli-responsive sheddable nanodaisies for efficient intracellular tumour-triggered drug delivery. J. Mater. Chem. B 2017 , 5 , 5027..
Pu, M. J.; Cao, H.; Zhang, H. J.; Wang, T. Y.; Li, Y. W.; Xiao, S. M.; Gu, Z. P. ROS-responsive hydrogels: from design and additive manufacturing to biomedical applications. Mater. Horiz. 2024 , 11 , 3721..
Li, Y. C.; Tanigawa, R.; Okuzaki, H. Soft and flexible PEDOT/PSS films for applications to soft actuators. Smart Mater. Struct. 2014 , 23 , 074010..
Mochizuki, Y.; Horii, T.; Okuzaki, H. Effect of pH on structure and conductivity of PEDOT/PSS. Trans. Mat. Res. Soc. Japan 2012 , 37 , 307..
de Kok, M. M.; Buechel, M.; Vulto, S. I. E.; van den Weijer, P.; Meulenkamp, E. A.; de Winter, S. H. P. M.; Mank, A. J. G.; Vorstenbosch, H. J. M.; Weijtens, C. H. L.; van Elsbergen, V. Modification of PEDOT:PSS as hole injection layer in polymer LEDs. Physica Status Solid A. 2004 , 201 , 1342..
Enshaei, H.; Puiggalí-Jou, A.; Saperas, N.; Alemán, C. Conducting polymer nanoparticles for a voltage-controlled release of pharmacological chaperones. Soft Matter 2021 , 17 , 3314..
García-Fernández, A.; Lozano-Torres, B.; Blandez, J. F.; Monreal-Trigo, J.; Soto, J.; Collazos-Castro, J. E.; Alcañiz, M.; Marcos, M. D.; Sancenón, F.; Martínez-Máñez, R. Electro-responsive films containing voltage responsive gated mesoporous silica nanoparticles grafted onto PEDOT-based conducting polymer. J. Control. Rel. 2020 , 323 , 421..
He, G. Q.; Li, H.; Liu, J.; Hu, Y. L.; Liu, Y.; Wang, Z. L.; Jiang, P. Recent progress in implantable drug delivery systems. Adv. Mater. 2024 , 36 , 2312530..
Yuan, F.; Lin, D.; Zhang, Y.; Han, K.; Xu, Q.; Ma, H.; Huang, P. P.; Liu, Y.; Kong, L. D. Nanocomposite from alpha-tocopheryl succinate and chitosan-modified-graphene for efficient inhibition on choroidal melanoma via a chemotherapy-assisted-photothermal therapy. Chinese J. Polym. Sci. 2025 , 43 , 1387−1394..
Zhu, H. M.; Yu, J. W.; Ye, J. F.; Wu, Y. M.; Pan, J. T.; Li, Y. M.; Chen, C.; Zheng, L.; Liu, G.; Chu, C. C. Nanoparticle-mediated corneal neovascularization treatments: toward new generation of drug delivery systems. Chin. Chem. Lett. 2023 , 107648..
Li, M.; Chen, Z. F.; Liu, L.; Ma, X. Y.; Zou, J. Topical vitamin C promotes the recovery of corneal alkali burns in mice. J. Ophthalmol. 2021 , 2021 , 2406646..
Pal, S. C.; Das, M. C. Superprotonic conductivity of MOFs and other crystalline platforms beyond 10 −1 S cm −1 . Adv. Funct. Mater. 2021 , 31 , 2101584..
Yu, C. C.; Zhou, Y. D.; Yao, S.; Wang, Z. Y.; Ye, S. H.; Qi, R. B.; Hu, H.; Liu, K. K.; Wu, Y. B.; Lawson, T.; Yan, L.; Liu, Y.; Wu, W. W. A facile strategy to restore the optic nerve functionality using an injectable conducting hydrogel. Adv. Sci . 2025 , 2415601..
Wu, G.; Yu, C. F.; Wang, W. B.; Du, J. L.; Fu, Z. H.; Xu, G. L.; Li, M.; Wang, L. Mass spectrometry-based charge heterogeneity characterization of therapeutic mAbs with imaged capillary isoelectric focusing and ion-exchange chromatography as separation techniques. Anal. Chem. 2023 , 95 , 2548..
Pang, F. F.; Li, S.; Sun, W. Q.; Han, G. Z. Reversible conductivity modulation of PEDOT:PSS based on pH. Chem. Phys. 2017 , 186 , 246..
Guimard, N. K.; Gomez, N.; Schmidt, C. E. Conducting polymers in biomedical engineering. Polym. Sci. 2007 , 32 , 876..
Sousa, F.; Sarmento, B.; Neves-Petersen, M. T. Biophysical study of bevacizumab structure and bioactivity under thermal and pH-stresses. Acta Pharm. Nord. 2017 , 105 , 127..
Arvinte, T.; Palais, C.; Poirier, E.; Cudd, A.; Rajendran, S.; Brokx, S.; Dowd, J. Part 1: Physicochemical characterization of bevacizumab in undiluted 25 mg/mL drug product solutions: comparison of originator with a biosimilar candidate. J. Pharm. Biomed. Anal. 2019 , 175 , 112742..
Saini, N.; Lee, D. Y.; Yoon, M. H.; Awasthi, K. Unveiling the potential of Pt nanoparticle-decorated PEDOT:PSS membranes for efficient gas separation. ACS Appl. Mater. Interfaces. 2024 , 16 , 7700..
Heredia Rivera, U.; Kadian, S.; Nejati, S.; White, J.; Sedaghat, S.; Mutlu, Z.; Rahimi, R. Printed low-cost PEDOT: PSS/PVA polymer composite for radiation sterilization monitoring. ACS Sens. 2022 , 7 , 960..
Papadopoulos, N.; Martin, J.; Ruan, Q.; Rafique, A.; Rosconi, M. P.; Shi, E.; Pyles, E. A.; Yancopoulos, G. D.; Stahl, N.; Wiegand, S. J. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis 2012 , 15 , 171..
Garcia, J.; Hurwitz, H. I.; Sandler, A. B.; Miles, D.; Coleman, R. L.; Deurloo, R.; Chinot, O. L. Chinot. Bevacizumab (Avastin®) in cancer treatment: a review of 15 years of clinical experience and future outlook. Cancer Treat. Rev. 2020 , 86 , 102017..
Dos Reis, T. F.; de Castro, P. A.; Bastos, R. W.; Pinzan, C. F.; Souza, P. F. N.; Ackloo, S.; Hossain, M. A.; Drewry, D. H.; Alkhazraji, S.; Ibrahim, A. S.; Jo, H.; Lightfoot, J. D.; Adams, E. M.; Fuller, K. K.; deGrado, W. F.; Goldman, G. H. A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi. Nat. Commun. 2023 , 14 , 2052..
0
Views
0
Downloads
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802046900号